CoChat

Protection against discrimination in national dementia guideline recommendations: A systematic review

Open access

The DOI matches its Crossref record; 29 of the 31 references it cites were found in a registry or an index.

Abstract

Background: National dementia guidelines provide recommendations about the most effective approaches to diagnosis and interventions. Guidelines can improve care, but some groups such as people with minority characteristics may be disadvantaged if recommended approaches are the same for everyone. It is not known if dementia guidelines address specific needs related to patient characteristics. The objectives of this review are to identify which countries have national guidelines for dementia and synthesise recommendations relating to protected characteristics, as defined in the UK Equality Act 2010: age, disability, gender identity, marriage and civil partnership, pregnancy and maternity, race, religion or belief, sex, and sexual orientation. Methods and findings: We searched CINAHL, PsycINFO, and Medline databases and the Guideline International Network library from inception to March 4, 2020, for dementia guidelines in any language. We also searched, between April and September 2020, Google and the national health websites of all 196 countries in English and in each country’s official languages. To be included, guidelines had to provide recommendations about dementia, which were expected to be followed by healthcare workers and be approved at a national policy level. We rated quality according to the iCAHE guideline quality checklist. We provide a narrative synthesis of recommendations identified for each protected characteristic, prioritising those from higher-quality guidelines. Forty-six guidelines from 44 countries met our criteria, of which 18 were rated as higher quality. Most guidelines (39/46; 85%) made at least one reference to protected characteristics, and we identified recommendations relating to age, disability, race (or culture, ethnicity, or language), religion, sex, and sexual orientation. Age was the most frequently referenced characteristic (31/46; 67%) followed by race (or culture, ethnicity, or language; 25/46; 54%). Recommendations included specialist investigation and support for younger people affected by dementia and consideration of culture when assessing whether someone had dementia and providing person-centred care. Guidelines recommended considering religion when providing person-centred and end-of-life care. For disability, it was recommended that healthcare workers consider intellectual disability and sensory impairment when assessing for dementia. Most recommendations related to sex recommended not using sex hormones to treat cognitive impairment in men and women. One guideline made one recommendation related to sexual orientation. The main limitation of this study is that we only included national guidelines applicable to a whole country meaning guidelines from countries with differing healthcare systems within the country may have been excluded. Conclusions: National guidelines for dementia vary in their consideration of protected characteristics. We found that around a fifth of the world’s countries have guidelines for dementia. We have identified areas of good practice that can be considered for future guidelines and suggest that all guidelines provide specific evidence-based recommendations for minority groups with examples of how to implement them. This will promote equity in the care of people affected by dementia and help to ensure that people with protected characteristics also have high-quality clinical services.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1003860

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 PRISMA flow diagram showing study selection. CINAHL, Cumulative Index to Nursing and Allied Health Literature; GIN, Guidelines International Network.
Fig 1 PRISMA flow diagram showing study selection. CINAHL, Cumulative Index to Nursing and Allied Health Literature; GIN, Guidelines International Network.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 39

  1. World Health Organization, 2017, Global action plan on the public health response to dementia 2017–2025.
  2. World Health Organization, 2018, The Global Dementia Observatory Reference Guide
  3. SMM Aye, 2018, Dementia: An overview.
  4. Department of Health, 2019, Appropriate prescribing of psychotropic medication for non-cognitive symptoms in people with dementia
  5. FCV Potocnik, 2013, Dementia, S Afr J Psychiatry, 19, 2013
  6. T. Jinzhou, 2017, Guidelines for the diagnosis and treatment of dementia in China
  7. T Nikolai, 2016, Neuropsychologická diagnostika kognitivního deficitu ve stáří., Ceskoslov Psychol, 60, 525
  8. Ravijuhend, 2017, Alzheimeri tõve diagnostika ja ravi.
  9. J Darovec, 2013, Smernice za obravnavo pacientov z demenco: Slovensko zdravniško društvo., Združenje psihiatrov
  10. Ministry of Health, 2010, Clinical protocol for providing medical care to patients with mental and behavioural disorders.
  11. L De Coninck, 2017, Multidisciplinaire richtlijn m.b.t. de samenwerking in de zorgverlening voor thuiswonende oudere personen met dementie en hun mantelzorgers, Internet]. Werkgroep Ontwikkeling Richtlijnen Eerste Lijn
  12. Suomalaisen Lääkäriseuran Duodecimin, 2020, Suomen Neurologisen Yhdistyksen, Suomen Psykogeriatrisen Yhdistyksen ja Suomen Yleislääketieteen yhdistyksen asettama työryhmä. Muistisairaudet. Käypä hoito -suositus
  13. Ministry of Health and Social Development (MoHSD), 2015, Clinical protocol of diagnostics and treatment for dementia in Alzheimer’s disease
  14. Centro Nacional de Excelencia Tecnológica en Salud (CENTEC), 2017, Diagnóstico y Tratamiento de la Enfermedad de Alzheimer. Guía de Evidencias y Recomendaciones: Guía de Práctica Clínica.
  15. Competence Center Integrierte Versorgung (CCIV), 2011, Besser leben mit demenz. Medizinische leitlinie für die integrierte versorgung demenzerkrankter.
  16. Instituto de Evaluación Tecnológica en Salud, 2017, Guía de Práctica Clínica para el diagnóstico y tratamiento del trastorno neurocognoscitivo mayor (Demencia)
  17. Health Ministry of Labor, 2009, MoLHS) of Georgia. Detection and management of dementia in general practice: National recommendations for clinical guidelines
  18. Ministry of Health (MoH) Republic of Macedonia, 2015, Guidelines for practicing evidence-based medicine: Psychaitry
  19. Ministry of Health Malaysia, 2009, Management of dementia
  20. Ministry of Health Singapore, 2013, Dementia
  21. Ministry of Health Ukraine, 2016, Unified clinical protoocl for primary, secondary (specialised), third (highly specialised) and palliative medical care: Dementia
  22. Latvijas Neirodeģeneratīvo slimību asociācija, 2017, Alcheimera slimības, vaskulāras demences, Levi ķermenīšu demences un frontotemporālās demences klīniskās vadlīnijas
  23. Helsedirektoratet, 2017, Nasjonal faglig retningslinje om demens
  24. Socialstyrelsen, 2017, Vård och omsorg vid demenssjukdom Stöd för styrning och ledning
  25. Japanese Society of Neurology, 2017, Dementia Disease Treatment Guidelines
  26. Nederlandse Vereniging voor Klinische Geriatrie, 2020, Dementia
  27. Ministério da Saúde, 2017, Protocolo clínico e diretrizes terpéuticas para doença de Alzheimer
  28. A Donoso, 2005, Guías clinicas de trastornos cognitivos y demencias en al adulto mayor
  29. Ministerio de Salud, 2017, Norma nacional de atentión a personas adultas con deterio cognitivo y demencia
  30. Haute Autorité de Sante (HAS), 2011, Recommandation de bonne pratique
  31. Ministry of Health, 2014, Recommendations for diagnosis and treatment of Alzheimer’s disease and related disorders
  32. Ministry of Health, 2013, New Zealand Framework for Dementia Care
  33. Ministry of Health and Social Development (MoHSD) of the Russian Federation, 2013, Federal clinical guidelines for the diagnosis and treatment of Alzheimer’s disease
  34. Ministry of Health (MoH) of the Republic of Serbia, 2013, National guide to good clinical practices for the diagnosis and treatment of Alzheimer’s disease
  35. Ministerstvo zdravotníctva Slovenskej republiky, 2020, Demencia pri Alzheimerovej chorobe
  36. Schweizerische Akademie der Medizinischen Wissenschaften (SAMW), 2018, Medizin-ethische Richtlinien: Betreuung und Behandlung von Menschen mit Demenz
  37. Prasat Neurological Institute (PNI) and the Department of Medical Services under the Ministry of Public Health, 2012, Clinical practice guidelines: Dementia
  38. Ministro de Salud Pública, 2015, Recomendaciones para el Abordaje Integral de la Demencia
  39. World Health Organisation, 2021, Global status report on the public health response to dementia.

Cited by

See all 23

Metadata

Authors
James, T., Mukadam, N., Sommerlad, A., Pour, H. R., Knowles, M., Azocar, I., & Livingston, G.
Affiliations
  • University College London (GB)
  • South London and Maudsley NHS Foundation Trust (GB)
  • Camden and Islington NHS Foundation Trust (GB)
Corresponding author
James, Tiffeny
Venue
PLOS Medicine
Published
2022-01-11
Volume
19
Issue
1
Pages
e1003860
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W4206453934
Cited by
23
References
31
Citations by year
2025: 8 · 2024: 8 · 2023: 6 · 2022: 1
FWCI
0.99
Type
journal article
Language
en
Open access
Locations
  • PLoS Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UCL Discovery (University College London) (submittedVersion)
Funders
national institute for health research (NIHR 200163)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Cultural Competency in Health Care
Keywords
dementia, national clinical guidelines, protected characteristics, discrimination, equality, age, disability, race and ethnicity, sex, sexual orientation, person-centred care, end-of-life care, intellectual disability, sensory impairment, sex hormones, cognitive impairment, guideline quality, health care equity, international comparison of guidelines
MeSH terms
Dementia, United Kingdom, Humans, National Health Programs, Prejudice, Guidelines as Topic, Social Discrimination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protection against discrimination in national dementia guideline recommendations: A systematic review. https://app.cochat.ai/papers/10.1371/journal.pmed.1003860
The paper
James, T., Mukadam, N., Sommerlad, A., Pour, H. R., Knowles, M., Azocar, I., & Livingston, G. (2022). Protection against discrimination in national dementia guideline recommendations: A systematic review. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1003860

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.